Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Journal of Inherited Metabolic Disease|January 26, 2006
Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell developmentM A Baxter, R F Wynn, L Schyma, et al.Cancer Metastasis Reviews|September 1, 1996
Chemoprotection of normal tissues by transfer of drug resistance genesJ A Rafferty, I Hickson, N Chinnasamy, et al.Mutation Research|September 8, 1999
Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus testP Rajaguru, L J Fairbairn, J Ashby, et al.Blood|March 1, 1997
O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrowN Chinnasamy, J A Rafferty, I Hickson, et al.Casopis Lekaru Ceskych|January 8, 1997
[Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?]J Jelínek, L J Fairbairn, T M Dexter, et al.Leukemia|October 6, 2000
The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrowS D Turner, J A Rafferty, L J Fairbairn, et al.Mutation Research|August 23, 2001
Assays to predict the genotoxicity of the chromosomal mutagen etoposide -- focussing on the best assayS D Turner, S W Wijnhoven, H Tinwell, et al.Gene Therapy|September 25, 1998
Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitroI Hickson, L J Fairbairn, N Chinnasamy, et al.Gene Therapy|September 25, 1998
Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferaseN Chinnasamy, J A Rafferty, I Hickson, et al.Gene Therapy|September 1, 1999
A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agentsJ Jelinek, J A Rafferty, R Cmejla, et al.Pageof 4